Retinoblastoma seeds: impact on American Joint Committee on Cancer clinical staging

dc.contributor.authorAnkit Singh Tomar, Ankit Singh
dc.contributor.authorFinger, Paul T
dc.contributor.authorGallie, Brenda
dc.date.accessioned2023-06-04T19:23:38Z
dc.date.available2023-06-04T19:23:38Z
dc.date.issued2021-07-10
dc.description.abstractAim To investigate whether the American Joint Committee on Cancer (AJCC) clinical category cT2b needs to be sub classified by the type and distribution of retinoblastoma (RB) seeding. Methods Multi centre, international registry-based data were collected from RB centres enrolled between January 2001 and December 2013. 1054 RB eyes with vitreous or sub retinal seeds from 18 ophthalmic oncology centres, in 13 countries within six continents were analysed. Local treatment failure was defined as the use of secondary enucleation or external beam radiation therapy (EBRT) and was estimated with the Kaplan-Meier method. Results Clinical category cT2b included 1054 eyes. Median age at presentation was 16.0 months. Of these, 428 (40.6%) eyes were salvaged, and 430 (40.8%) were treated with primary and 196 (18.6%) with secondary enucleation. Of the 592 eyes that had complete data for globe salvage analysis, the distribution of seeds was focal in 143 (24.2%) and diffuse in 449 (75.8%). The 5-year Kaplan-Meier cumulative globe-salvage (without EBRT) was 78% and 49% for eyes with focal and diffuse RB seeding, respectively. Cox proportional hazards regression analysis confirmed a higher local treatment failure risk with diffuse seeds as compared with focal seeds (hazard rate: 2.8; p<0.001). There was insufficient evidence to prove or disprove an association between vitreous seed type and local treatment failure risk(p=0.06). Conclusion This international, multi centre, registry based analysis of RB eyes affirmed that eyes with diffuse intraocular distribution of RB seeds at diagnosis had a higher risk of local treatment failure when compared with focal seeds. Sub classification of AJCC RB category cT2b into focal vs diffuse seeds will improve prognostication for eye salvageen_US
dc.description.sponsorshipACE: Genetic Medicineen_US
dc.identifier.urihttp://hdl.handle.net/123456789/1896
dc.language.isoenen_US
dc.publisherBr J Ophthalmolen_US
dc.relation.ispartofseriesBr J Ophthalmol;l 2021;0
dc.subjectRetinoblastomaen_US
dc.subjectTero Kiveläen_US
dc.subjectAshwin Mallipatnaen_US
dc.subjectUniversity of Ghanaen_US
dc.subjectWAGMCen_US
dc.subjectACE: Genetic Medicineen_US
dc.titleRetinoblastoma seeds: impact on American Joint Committee on Cancer clinical stagingen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
retinoblast.pdf
Size:
695.11 KB
Format:
Adobe Portable Document Format
Description:
Main article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Collections